Taken together, this study demonstrates DYNLT1-Parkin-VDAC1 axis to be a new mechanism that underlies the mitochondrial metabolism for breast cancer development, improving our mechanistic understanding on the mitochondrial metabolism in breast cancer and providing new targets for future development of mitochondrial inhibitors to suppress breast cancer. This evidence concerns the gene VDAC1 and breast carcinoma.